Moreover, immunostaining for CD45 failed to reveal differences in immune cell infiltration between the three genotypes, arguing that inhibition of TNFR1 signaling did not change the immune landscape of SCLC (Fig. 8D). This evidence concerns the gene PTPRC and small cell lung carcinoma.